Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017106
University of Pennsylvania, Philadelphia, PA, United States
Search grants from University of Pennsylvania
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Calcium Sparklers-Induced Vascular Dysfunction During Diabetes
Hypothalmic Circuits Regulating Energy Balance and Obesity: Synaptic Physiology
Molecular mechanisms of tumor response to cytotoxic chemotherapy
Rescue of broadly neutralizing mAbs using native trimer
Redox-Sensitive &Blood-pool Contrast Agents for Magnetic Resonance Imaging
Recently added grants:
Improved staging of lobular breast cancer with novel amino acid metabolic and tumor neovasculature receptor imaging.
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease
A novel technology to assess chronic toxicity in genetically diverse nematode populations
In Vitro Toxicity Testing at Massive Scale in Diverse Primary Human Cells
BP-ENDURE at the University of Nevada
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017106-004
Application #
6828838
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Related projects
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017106
/ University of Pennsylvania
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017106
/ University of Pennsylvania
Publications
Ruszczyk, Melanie; Zirpoli, Gary; Kumar, Shicha et al.
(2016)
Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
Cancer Causes Control 27:183-98
Comments
Be the first to comment on this grant